Article: Gene therapy for cystic fibrosis patients.

Three teams of scientists received approval last week from a national panel of physicians and ethicists to administer gene therapy to a limited number of adults with cystic fibrosis -- the most common lethal hereditary disorder in the United States.

The National Institutes of Health's Recombinant DNA Advisory Committee (RAC) voted to allow each team to squirt solutions of genetically engineered cold viruses into the nasal passages and lungs of patients. The scientists hope the viruses will ferry corrected copies of the defective gene that causes cystic fibrosis into patients' airways, reducing production of the thick, lung-clogging mucus characteristic of the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!